Efficacy of standard 1st category regimen of chemotherapy in patients with smear positive destructive pulmonary tuberculosis in Chernovetskaya Oblast, Ukraine Source: Eur Respir J 2006; 28: Suppl. 50, 379s Year: 2006
Efficacy of standard chemotherapy regimen in patients with newly detected sputum-positive destructive pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 40s Year: 2003
Results of standard treatment of new patients with pulmonary tuberculosis in Ivanovo oblast, Russia Source: Eur Respir J 2001; 18: Suppl. 33, 175s Year: 2001
The assessment of the efficacy of a standard chemotherapy regimen in the treatment of new sputum-positive tuberculosis (TB) patients Source: Eur Respir J 2001; 18: Suppl. 33, 340s Year: 2001
Efficacy of a standard chemotherapy regimen in the management of sputum-positive pulmonary TB relapses Source: Eur Respir J 2003; 22: Suppl. 45, 41s Year: 2003
Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002
Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev Source: Eur Respir J 2002; 20: Suppl. 38, 548s Year: 2002
Effectiveness of chemotherapy in newly detected patients with pulmonary tuberculosis with poly-resistance Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Treatment results of new cases of sputum-positive pulmonary tuberculosis with standard chemotherapeutical regimen Source: Eur Respir J 2002; 20: Suppl. 38, 367s Year: 2002
The results of the antituberculosis treatment to the patients with pulmonary tuberculosis in Bucharest (Romania) in 2001 Source: Annual Congress 2003 - Management of tuberculosis and tubercular infection - old and new considerations Year: 2003
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009
The significance of positive smear results at T2 in pulmonary tuberculosis - Iasi (Romania) DOTS pilot study Source: Eur Respir J 2001; 18: Suppl. 33, 313s Year: 2001
Directly observed therapy versus self administered therapy for patients of new smear positive pulmonary tuberculosis during hospitalisation period Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004
Development of multi-drug resistant tuberculosis among patients treated with category II regimen: A lung center of the Philippines experience Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Assessment of the results of the chemotherapy administrated to the patients with pulmonary tuberculosis in Bucharest (Romania) in 2000 Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
The effectiveness of the treatment of patients with TB in the condition adapted DOTS-strategy in Ukraine Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008
Molecular-genetic and microbiological study of lung resection tissues from tuberculosis patients in Ural region, Russia Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016
Multicentre randomised clinic study of new standard chemotherapy regimen for new cases patients of pulmonary tuberculosis executed in Russia regions with high level of multiple drug resistance (MDR) Source: Annual Congress 2009 - Tuberculosis control Year: 2009
Results of treatment administered to the patients with pulmonary tuberculosis in Bucharest, Romania, 2004 Source: Eur Respir J 2006; 28: Suppl. 50, 302s Year: 2006